Lifesaving treatments for people with severe covid-19 are still in short supply, but new results from a large ongoing trial in the UK have found that an existing arthritis drug called tocilizumab can noticeably lower hospitalized patients’ risk of dying, especially when combined with steroid treatment.
No comments:
Post a Comment